These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 21565614)

  • 1. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.
    Brady CA; Jiang D; Mello SS; Johnson TM; Jarvis LA; Kozak MM; Kenzelmann Broz D; Basak S; Park EJ; McLaughlin ME; Karnezis AN; Attardi LD
    Cell; 2011 May; 145(4):571-83. PubMed ID: 21565614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence.
    Johnson TM; Meade K; Pathak N; Marques MR; Attardi LD
    Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1215-20. PubMed ID: 18216268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing p53 transcriptional networks in tumor suppression.
    Bieging KT; Attardi LD
    Trends Cell Biol; 2012 Feb; 22(2):97-106. PubMed ID: 22154076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages.
    Jiang D; Brady CA; Johnson TM; Lee EY; Park EJ; Scott MP; Attardi LD
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17123-8. PubMed ID: 21969549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deconstructing networks of p53-mediated tumor suppression in vivo.
    Kaiser AM; Attardi LD
    Cell Death Differ; 2018 Jan; 25(1):93-103. PubMed ID: 29099489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.
    Li T; Kon N; Jiang L; Tan M; Ludwig T; Zhao Y; Baer R; Gu W
    Cell; 2012 Jun; 149(6):1269-83. PubMed ID: 22682249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence.
    Tavana O; Benjamin CL; Puebla-Osorio N; Sang M; Ullrich SE; Ananthaswamy HN; Zhu C
    Cell Cycle; 2010 Aug; 9(16):3328-36. PubMed ID: 20703098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA damage responses in p53 biology.
    Speidel D
    Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling mechanisms of p53-mediated tumour suppression.
    Bieging KT; Mello SS; Attardi LD
    Nat Rev Cancer; 2014 May; 14(5):359-70. PubMed ID: 24739573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression.
    Toledo F; Lee CJ; Krummel KA; Rodewald LW; Liu CW; Wahl GM
    Mol Cell Biol; 2007 Feb; 27(4):1425-32. PubMed ID: 17158931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription activity is required for p53-dependent tumor suppression.
    Gaidarenko O; Xu Y
    Oncogene; 2009 Dec; 28(49):4397-401. PubMed ID: 19767771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
    Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
    Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Transactivation Domains of the p53 Protein.
    Raj N; Attardi LD
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27864306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical suppression of cellular senescence by p53.
    Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
    Ponnamperuma RM; King KE; Elsir T; Glick AB; Wahl GM; Nister M; Weinberg WC
    J Pathol; 2009 Oct; 219(2):263-74. PubMed ID: 19718706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
    Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
    Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
    Kenzelmann Broz D; Attardi LD
    Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust p53 Stabilization Is Dispensable for Its Activation and Tumor Suppressor Function.
    Kon N; Churchill M; Li H; Mukherjee S; Manfredi JJ; Gu W
    Cancer Res; 2021 Feb; 81(4):935-944. PubMed ID: 33323382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.